Meta loses $200 billion in value as Zuckerberg focuses earnings call on all the ways company bleeds cash
Meta CEO Mark Zuckerberg spooked investors on the company’s quarterly earnings call Wednesday.
Standard Chartered doubles down on its prediction that bitcoin will reach $150,000 by the end of the year
Bitcoin is set for more price gains later this year, even after a recent retreat in prices, according to Standard Chartered’s top crypto analyst.
‘Greater tailwind than the U.S.’: Morningstar strategist likes these 7 European stocks
“There could … be a greater tailwind for European equities than those in the U.S.,” Michael Field says.
Nikkei leads losses in Asia markets as rally halts; South Korea beats first-quarter GDP expectations
South Korea’s first-quarter GDP climbed 3.4%, beating expectations of 2.4% from economists polled by Reuters.
Stock futures fall as Meta Platforms shares sell off after earnings: Live updates
U.S. stock futures fell Thursday after tech juggernaut Meta Platforms reported quarterly results that disappointed investors.
S&P 500 closes little changed as higher bond yields dampen earnings enthusiasm
Stocks wavered Wednesday as interest rate fears dampened the enthusiasm stemming from a strong slate of corporate earnings.
Rubrik prices IPO at $32 per share, above the expected range
Rubrik is hitting the market at a historically slow time for venture-backed tech IPOs.
IBM to acquire HashiCorp in $6.4 billion deal, reports another revenue miss
IBM said it would buy HashiCorp, a cloud software maker that’s growing at a faster pace. IBM reported its third revenue miss in five quarters.
I study wellbeing in Denmark, one of the world’s happiest countries: Here are 3 phrases we say every day
Denmark is one of the happiest countries in the world. Happiness Research Institute CEO Meik Wiking reveals three commonly used phrases that help explain why.
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.
